Navigation Links
Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource
Date:9/4/2008

COLD SPRING HARBOR, N.Y. (Sept. 4, 2008) A variety of organismsfrom bacteria and fungi to plants and animalshave biological rhythms, where the timing and duration of fundamental biological processes is naturally adjusted to allow them to adapt and survive, even under fluctuating environmental conditions. In recent years, significant advances have been made to understand the molecular basis of these rhythms and how they translate into modifications in cellular physiology and organismal behavior.

A new book from Cold Spring Harbor Laboratory Press, Clocks and Rhythms, reviews the latest advances in biological clocks and rhythms across a broad range of species and biological disciplines. Chapters in the book are based on presentations by world-renowned investigators at the 72nd annual Cold Spring Harbor Symposium on Quantitative Biology at Cold Spring Harbor Laboratory, which was attended by 316 scientists from more than 20 countries.

"Since the discovery and cloning of the first clock gene, period, more than 20 years ago, tremendous progress has been made about the nature of the clock and how it functions in a wide variety of different plants and animals," wrote the meeting organizers, Bruce Stillman, David Stewart, and Terri Grodzicker, in the Foreword to the book. "Research previously limited to describing 'the hands of the clock' has been enormously successful in recent years in describing the inner anatomy and mechanism of the clock in individual cells and in the whole organism."

The first section of Clocks and Rhythms provides an overview of the field of biological rhythms, providing an introduction to the field of chronobiology, as well as primers on the molecular basis of biological rhythms, pacemakers, and sleep. Subsequent sections of the book offer in-depth discussions on specific topics, including genetic and cellular studies aimed at characterizing circadian mechanisms; systems approaches to u
'/>"/>

Contact: Ingrid Benirschke
benirsch@cshl.edu
619-275-6021
Cold Spring Harbor Laboratory
Source:Eurekalert  

1

GOOD

Page: 1 2

Related biology news :

1. Conference on healthspan offers new opportunities for interdisciplinary collaboration
2. Primates scent speaks volumes about who he is
3. New study shows Dermytol produces pronounced decrease in malignant melanoma tumor volume
4. Biological invasions increasing due to freshwater impoundments, says CU-Boulder study
5. Study shows more genes are controlled by biological clocks
6. Light receptors in eye play key role in setting biological clock, study shows
7. Francisella tularensis: Stopping a biological weapon
8. Tips on how to build a better home for biological parts
9. Genomics of large marine animals showcased in the biological bulletin
10. Securing the future of Europes biological data resources
11. Religion and the narrative of biological science
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource
Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource
(Date:12/3/2009)... change in warmer water, according to an intriguing new study ... , Experiments with two species of young damselfish on Australia,s ... some reef fish are either consistently timid, or consistently bold, ... water temperatures rise. , A slight lift of just one ...
(Date:12/3/2009)... to investment in energy efficient technologies research, but Engineering ... Delpy believes that more is needed: "Scientific and engineering ... and solar power solutions, but more investment is needed ... are to meet our carbon emission targets by 2020 ...
(Date:12/2/2009)... acculturated Latino men have a more difficult time quitting ... culture, but acculturation has no affect on Latinas odds ... in Cancer Epidemiology, Biomarkers & Prevention , a ... December issue has a special focus on tobacco. , ...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Research is vital to a cleaner, greener, low carbon future 2Acculturation affects smoking cessation success among Latinos 2DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 1DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 2DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 4American Society of Plastic Surgeons hosts 78th annual meeting 58275 1American Society of Plastic Surgeons hosts 78th annual meeting 58275 2American Society of Plastic Surgeons hosts 78th annual meeting 58275 3World Heart Day resonates with recent experts findings on CVD and EU institutions determination to promote heart health 58272 1World Heart Day resonates with recent experts findings on CVD and EU institutions determination to promote heart health 58272 2World Heart Day resonates with recent experts findings on CVD and EU institutions determination to promote heart health 58272 3
... sure-to-be-controversial new study, Emily Oster (a graduate student in ... such as infanticide, may not be the only cause ... Asian countries. It has long been observed that the ... countries than in the West, where it is close ...
... of York's Department of Chemistry have developed a gel ... and dangerous side-effects of radiotherapy. , PhD students Andrew ... Mark Godber, have developed the gel which will help ... the group has secured £30,000 under the Bioscience Yorkshire ...
... an increased risk of hypertension in women, although an ... diet colas, according to a study in the November ... in the United States have hypertension, and the prevalence ... Hypertension is a major risk factor for coronary heart ...
Other Biology News:Young scientists turn to gel to ease side-effects of cancer treatment 2No link found between caffeine intake and development of hypertension in women 2
(Date:12/2/2009)... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion ... trial of Cotara® in patients with relapsed glioblastoma multiforme ... is a targeted monoclonal antibody linked to a radioisotope ... Cotara specifically targets cells at the center of ...
(Date:12/2/2009)... Pepscan Holding NV,the Netherlands based biotechnology company focusing on ... announced that it,has appointed Wim E.M. Mol, Ph.D. as ... Dr. Mol will be responsible for all of Pepscans ... the company. He brings to,Pepscan more than 20 years ...
(Date:12/2/2009)... today announced data presentations on its novel oral JAK2 ... Annual Meeting and Exposition in New Orleans. ,, Data ... Phase 1 dose-escalation trial of SB1518 detailing its safety, ... from 100 to 600 mg. These doses were administered ...
(Date:12/2/2009)... /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ... company focused on endocrine therapy and oncology, today ... (FDA) has granted Fast Track designation for the ... the treatment of relapsed/refractory multiple myeloma. Keryx Biopharmaceuticals, ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
... gathered , if your PCR yields no product:, , , , , , , ... , , Non-optimal , ... , , The amount of , ... , , , ...
... , , , , , , , Here are ... , , , , , , ... , <a , ... , , , ...
... , Cat. No. 3 315 932, 25 ml (25 vials of 1 ml) ... , Cat. No. 3 315 843, 100 ml (4 vials of 25 ml)) , ... , , , Specially purified, double distilled, deionized, auto-claved water ... Routinely function checked in PCR pH at 20C: 8.3 , , , ...
Other Biology Technology:Trouble-shooting: No product 2Trouble-shooting: No product 3Trouble-shooting: No product 4Trouble-shooting: No product 5Trouble-shooting: Low yield 2Trouble-shooting: Low yield 3Trouble-shooting: Low yield 4Trouble-shooting: Low yield 5Trouble-shooting: Low yield 6Trouble-shooting: Low yield 7PCR Grade Water 2
... the Flp-In System creates isogenic cell ... levels of the protein of interest. ... Figure 3 (click link below). In ... chloramphenicol-acetyl transferase (CAT) was subcloned into ...
Growth Medium / Media...
...
Recombinant Rat Leptin, CF...
Biology Products: